Pharma Journalist -

Vedana Therapeutics has emerged from stealth mode with $46 million in Series A financing and ambitious plans to develop next-generation therapies for migraine prevention, targeting…
Read More...

LG AI Research and D&D Pharmatech have entered into a strategic partnership aimed at accelerating the development of next-generation oral peptide therapies, highlighting the growing…
Read More...

Jazz Pharmaceuticals and AbCellera have entered into a new research collaboration aimed at developing next-generation antibody-based treatments for gastrointestinal (GI) cancers and…
Read More...

Biogen has agreed to acquire private biotechnology company RayThera in a deal valued at up to $1 billion, strengthening the company's growing focus on immunology and expanding its…
Read More...

Insilico Medicine has announced a significant milestone in the development of its experimental drug candidate ISM8969, marking the first time the therapy has been administered to…
Read More...

Eli Lilly and Company has acquired 4E Therapeutics, a privately held neuroscience biotechnology company focused on developing next-generation therapies for chronic pain, strengthening…
Read More...

Simulations Plus, a leading provider of model-informed and AI-enabled drug development software and services, has agreed to be acquired by healthcare-focused investment firm Altaris in…
Read More...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) and the U.S. Food and Drug Administration (FDA) have announced a new liaison programme aimed at strengthening…
Read More...

SpliSense has secured a funding commitment of up to $13 million from the Cystic Fibrosis Foundation to support the continued clinical development of its lead investigational therapy,…
Read More...

AviadoBio has expanded its partnership with King’s College London, securing exclusive rights to apply the vMiX™ RNA interference (RNAi) gene-silencing platform across all human…
Read More...